Access
To read this article in full you will need to log-in or choose from the options on the right.
Distillery: Therapeutics - Metabolic disease
SciBX 1(9); doi:10.1038/scibx.2008.218
Published online March 27 2008
Extra navigation
Solute carrier family 2 (facilitated glucose transporter), member 9 (SLC2A9)
A genome-wide association study identified a urate transporter protein that might contribute to high levels of serum uric acid and thus be a useful target for treating gout. Further details on the research, next steps and licensing status are discussed in the article.
To read this article in full you will need to log-in or choose from the options on the right.
